Skip to main content
. Author manuscript; available in PMC: 2014 Apr 16.
Published in final edited form as: Circulation. 2013 Apr 16;127(15):1630–1635. doi: 10.1161/CIRCULATIONAHA.112.000779

Figure 2.

Figure 2

The traditional end-point hierarchy for end points in a phase III clinical trial. A small number of primary end points with multiplicity error correction are supported by a larger number of secondary end points. The largest number of end points are non-prospectively declared exploratory end points.